ANGEL BROWN: Open Payments
NPI 1700350444 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 9 payments from 7 companies in 2025. Trend: 2023 $233 · 2024 $65 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Ozempic, NURTEC ODT, Symbravo, REXULTI, SHINGRIX, MOUNJARO, PREVNAR 20, FARXIGA.
Industry payments across SC — which companies pay providers there.
